 |
 |
|
|
|
| Cefotaxime Sodium |
 |
| C16H16N5O7S2•Na |
 |
| 64485-93-4 |
 |
Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints
treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms
perioperative prophylaxis.
|
 |
Cefotaxime Sodium
¡¤ CAS Number:64485-93-4
¡¤ Molecular Formula:C16H16N5O7S2•
Na
¡¤ Molecular Weight:477.48
¡¤ EINECS:264-915-9
¡¤ Solubility:H2O: aqueous solutions of 4.3-6.2 are stable up to 3 weeks at 2-8 ¡ãC.soluble
Appearance:white to yellow powder
Properties:A solid. Mp: 162-163¡ã (decomp).
Indications and Usage £ºTreatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints
treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms
perioperative prophylaxis. |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
